Clinical Trial

The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial)

Study acronym: INCyst
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial research study is to evaluate the impact of preoperative oral immunonutrition (IN) on post-operative complications in patients undergoing a cystectomy. As a secondary focus, this study will aim to develop a signature that would identify patients that would benefit the most from IN. This is a multicentric (Swiss: N=3), prospective, controlled, pragmatic, parallel-group comparative study with block randomization stratified by centers.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-02-03; most recent amendment 2025-12-02.
Status change: Not Yet Recruiting → Recruiting 2023-04-13
Trial Details
NCT Number NCT05726786
Lead Sponsor Centre Hospitalier Universitaire Vaudois
Collaborators: Insel Gruppe AG, University Hospital Bern, Hôpital Riviera-Chablais, Vaud-Valais, University Hospital, Geneva
Conditions Bladder Cancer, Interstitial Cystitis, Painful Bladder Syndrome, Neurogenic Bladder, Hemorrhagic Cystitis, Endometriosis, Bladder Disease
Enrollment 232 participants
Start Date 2023-04-10
Primary Completion 2026-08 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2025-12-09